Two Sigma Advisers’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Two Sigma Advisers’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-475,700	Closed	-$1.9M	–	2649
2019 Q4	$1.9M	Buy	475,700 +186,100	+64%	+$874K	﹤0.01%	1248
2019 Q3	$1.42M	Buy	289,600 +112,700	+64%	+$631K	﹤0.01%	1275
2019 Q2	$1.08M	Buy	176,900 +148,500	+523%	+$789K	﹤0.01%	1480
2019 Q1	$165K	Buy	+28,400	New	+$293K	﹤0.01%	2143
2017 Q2	–	Sell	-38,689	Closed	-$617K	–	2470
2017 Q1	$617K	Sell	38,689 -81,068	-68%	-$1.17M	﹤0.01%	1803
2016 Q4	$1.51M	Buy	+119,757	New	+$2.23M	0.01%	1330

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Two Sigma Advisers's DPLO Position: Q1 2020 in Review

Two Sigma Advisers sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 475,700 shares — an estimated $1.9M sold.

Two Sigma Advisers first reported a position in DPLO in Q4 2016 and held it in 6 quarters. The position peaked at $1.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Two Sigma Advisers reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Two Sigma Advisers sold 475,700 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.9M.
Two Sigma Advisers first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 6 quarters.
Two Sigma Advisers's DIPLOMAT PHARMACY, INC. position peaked at $1.9M in Q4 2019.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Two Sigma Advisers's 13F filing for Q1 2020, filed 15 May 2020.